Refractory Hypertension: A Novel Phenotype of Antihypertensive Treatment Failure
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
The term resistant hypertension has been used since the early 1960s to identify patients with difficult-to-treat hypertension, meaning mostly, resistance to pharmacological therapy.1 In the 5 decades since the term was seemingly first applied, resistant hypertension has been consistently defined as failure to control high blood pressure despite of use of ≥3 antihypertensive agents of different classes, including a diuretic.2–5 The 2008 American Heart Association Scientific Statement on resistant hypertension included in its definition patients whose blood pressure had been uncontrolled with 3 medications, but controlled with ≥4 medications.4 Although the number of medications required to satisfy the definition is arbitrary, the purpose of creating a category of resistant hypertension is to identify patients who, because of the difficulty in controlling their blood pressure, may benefit from special diagnostic and therapeutic considerations, including referral to a hypertension specialist. Having an agreed on definition that can be reliably applied to different cohorts has also facilitated research for this subgroup of patients, including identification of risk factors and underlying mechanisms, assessing outcomes and developing targeted treatments. The term refractory hypertension has often been used interchangeably with resistant hypertension to also refer to patients with difficult-to-treat hypertension.1–3,5 However, based on the number of respective PubMed citations resistant hypertension has been used much more often than refractory hypertension to indicate patients with hypertension resistant to pharmacological treatment. Recently, the term refractory hypertension has been applied to a small group of patients who are truly refractory to treatment, that is, patients who fail to achieve target blood pressure on maximal antihypertensive therapy.6 Determining whether such patients simply represent extreme cases of resistant hypertension or a novel phenotype in terms of risk and cause has been the focus of initial attempts to define and characterize …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
de la Sierra, A., Segura, J., Banegas, J. R., Gorostidi, M., de la Cruz, J. J., Armario, P., Oliveras, A., & Ruilope, L. M. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.168948 · Cited by 809
Gaddam, K. K. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.11.1159 · Cited by 301
Muntner, P., Davis, B. R., Cushman, W. C., Bangalore, S., Calhoun, D. A., Pressel, S. L., Black, H. R., Kostis, J. B., Probstfield, J. L., Whelton, P. K., et al. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.03850 · Cited by 231
Self-citationThomas, G., Xie, D., Chen, H.-Y., Anderson, A. H., Appel, L. J., Bodana, S., Brecklin, C. S., Drawz, P., Flack, J. M., Miller, E. R., et al. (2016) · Hypertension · doi:10.1161/hypertensionaha.115.06487 · Cited by 190
Smith, S. M., Gong, Y., Handberg, E., Messerli, F. H., Bakris, G. L., Ahmed, A., Bavry, A. A., Pepine, C. J., & Cooper-DeHoff, R. M. (2014) · Journal of Hypertension · doi:10.1097/hjh.0000000000000051 · Cited by 115
Smith, S. M., Huo, T., Delia Johnson, B., Bittner, V., Kelsey, S. F., Vido Thompson, D., Noel Bairey Merz, C., Pepine, C. J., & Cooper‐DeHoff, R. M. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.113.000660 · Cited by 69
Are Chlorthalidone and Hydrochlorothiazide Equivalent Blood‐Pressure‐Lowering Medications?
Khosla, N., Chua, D. Y., Elliott, W. J., & Bakris, G. L. (2005) · The Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2005.04451.x · Cited by 61
Grigoryan, L., Pavlik, V. N., & Hyman, D. J. (2013) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2013.06.004 · Cited by 48
Cited by
International Consensus Statement on Obstructive Sleep Apnea
Chang, J. L., Goldberg, A. N., Alt, J. A., Mohammed, A., Ashbrook, L., Auckley, D., Ayappa, I., Bakhtiar, H., Barrera, J. E., Bartley, B. L., et al. (2023) · International Forum of Allergy & Rhinology · doi:10.1002/alr.23079 · Cited by 350
How to Screen for Non-Adherence to Antihypertensive Therapy
Gupta, P., Patel, P., Horne, R., Buchanan, H., Williams, B., & Tomaszewski, M. (2016) · Current Hypertension Reports · doi:10.1007/s11906-016-0697-7 · Cited by 84
Martínez-García, M.-A., Navarro-Soriano, C., Torres, G., Barbé, F., Caballero-Eraso, C., Lloberes, P., Diaz-Cambriles, T., Somoza, M., Masa, J. F., González, M., et al. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.11170 · Cited by 74
Sapiña-Beltrán, E., Torres, G., Benitez, I., Fortuna-Gutiérrez, A. M., Márquez, P. P., Masa, J. F., Corral-Peñafiel, J., Drager, L. F., Cabrini, M., Félez, M., et al. (2019) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201901-053oc · Cited by 64
Apneic Sleep, Insufficient Sleep, and Hypertension
Mansukhani, M. P., Covassin, N., & Somers, V. K. (2019) · Hypertension · doi:10.1161/hypertensionaha.118.11780 · Cited by 52
Metadata
- Authors
- Dudenbostel, T., Siddiqui, M., Oparil, S., & Calhoun, D. A.
- Venue
- Hypertension
- Published
- 2016-06
- Volume
- 67
- Issue
- 6
- Pages
- 1085-1092
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2338232244
- Cited by
- 77
- References
- 8
- FWCI
- 7.97
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Refractory Hypertension: A Novel Phenotype of Antihypertensive Treatment Failure. https://app.cochat.ai/papers/10.1161/hypertensionaha.116.06587
- The paper
- Dudenbostel, T., Siddiqui, M., Oparil, S., & Calhoun, D. A. (2016). Refractory Hypertension: A Novel Phenotype of Antihypertensive Treatment Failure. Hypertension. https://doi.org/10.1161/hypertensionaha.116.06587
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.